Molecular remodeling of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 immunotherapy

Collectively, these findings highlight the critical role of CAF heterogeneity and spatial organization in modulating the response to anti-PD-1 therapy. Targeting subtype-specific stromal modules may represent a promising therapeutic strategy to enhance the efficacy of immunotherapy in breast cancer.